There are several papers supporting the relevance of our findings in these AD model mice to postmortem brains from AD patients which exhibit higher brain tissue glucose concentration, reduced glycolytic flux, and lower GLUT3 associated with the severity of AD pathology [33] as well as decreased GAPDH and glycolytic activity in the AD brain [34]. This evidence concerns the gene SLC2A3 and Alzheimer disease.